Common Equity: The sum of all common equity items.
Enveric Biosciences, Inc. (ENVB) had Common Equity of $8.08M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.03M |
|
-- |
|
-- |
|
$3.03M |
|
$-3.03M |
|
$-0.00M |
|
$-3.03M |
|
$-3.03M |
|
$-3.03M |
|
$-3.03M |
|
$-3.03M |
|
$-3.03M |
|
$-3.03M |
|
$-2.99M |
|
3.99M |
|
3.99M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$8.79M |
|
$0.08M |
|
$0.15M |
|
$8.94M |
|
$0.86M |
|
-- |
|
-- |
|
$0.86M |
|
|
Common Equity |
$8.08M |
$8.08M |
|
$8.08M |
|
3.94M |
|
| Cash Flow Statement Financials | |
$-4.70M |
|
-- |
|
$8.35M |
|
$4.68M |
|
$8.30M |
|
$3.62M |
|
$0.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-37.46% |
|
-37.46% |
|
-33.85% |
|
-37.46% |
|
$2.05 |
|
$-1.18 |
|
$-1.18 |
|